|
ATRA Atara Biotherapeutics Inc 1604464 |
| Balance Sheet |
|
Current Assets
|
$12,173,000.00 |
|
Assets
|
$19,997,000.00 |
|
Current Liabilities
|
$5,645,000.00 |
|
Liabilities
|
$57,309,000.00 |
|
Equity
|
$-37,312,000.00 |
|
Shares Out
|
8512000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,073,000.00 |
| Market Analysis |
Market Cap
|
$69,543,040.00 |
|
Price
|
$8.27 |
|
PB
|
0.98 |
|
EPS
|
-0.29 |
|
PS
|
0.82 |
|
FCF
|
$-3,073,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:38 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:37 |
|
| Apr |
May |
Jun |
| 2026-03-16 |
-0.25 |
|
|
2026-05-12 |
-0.29 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
0.19 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-0.32 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ATRA documents filed with the SEC.
ATRA Filings
Clear
